These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3515683)

  • 1. Cyclosporine-associated renal arteriopathy.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):151-7. PubMed ID: 3515683
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient.
    Tolkoff-Rubin NE; Rubin RH
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):168-76. PubMed ID: 3008389
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion of cyclosporine to azathioprine in renal transplant patients.
    Shen SY; Zemel SM; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine nephrotoxicity and dermal vascular alterations in renal transplants.
    Shen SY; Wood C; Amin AN; Papadimitriou JC; Weir MR; Coughlin TR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1508-10. PubMed ID: 2652486
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation.
    First MR; Smith RD; Weiss MA; Schroeder TJ; Kant KS; Munda R; Stephens GW; Penn I; Alexander JW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1567-70. PubMed ID: 2652509
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
    Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
    First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680
    [No Abstract]   [Full Text] [Related]  

  • 9. Dallas experience with cyclosporine A (CsA) one to six months posttransplant.
    Hull AR; Atkins CR; Brinker KR; Dawidson I; Dickerman RM; Emerson W; Helderman JH; Levitz B; Long DL; Nesser D
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):128-31. PubMed ID: 3515679
    [No Abstract]   [Full Text] [Related]  

  • 10. Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin.
    Gruber SA; Pescovitz M; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Elick B; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1815-6. PubMed ID: 3079041
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion from cyclosporine to azathioprine in renal graft recipients.
    MacDonald AS; Belitsky P; Gupta R; Bitter-Suermann H; Campbell R; Cohen A; Lannon SG
    Transplant Proc; 1985 Aug; 17(4):1940-2. PubMed ID: 3895634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical renal transplantation.
    Sommer BG; Ferguson RM; Najarian JS
    Urol Clin North Am; 1983 Feb; 10(1):149-59. PubMed ID: 6340311
    [No Abstract]   [Full Text] [Related]  

  • 13. Avoidance of perioperative renal toxicity by a modified immunosuppression protocol.
    Kormos RL; Trento A; Hardesty RL; Griffith BP; Thompson M; Bahnson HT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2525-6. PubMed ID: 3274555
    [No Abstract]   [Full Text] [Related]  

  • 14. [The diagnosis of cyclosporin nephrotoxicity in patients after kidney transplantation].
    Rozental' RL; Il'inskiĭ IM; Bitsans IaB; Strokan' VA
    Ter Arkh; 1990; 62(6):92-4. PubMed ID: 2218937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
    Thistlethwaite JR; Woodle ES; Mayes JT; Stuart JK; Heffron TG; Spargo BH; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1890-2. PubMed ID: 2652614
    [No Abstract]   [Full Text] [Related]  

  • 16. [After care of kidney transplant patients].
    Castro LA; Eigler J; Land W
    Internist (Berl); 1983 Sep; 24(9):510-6. PubMed ID: 6313541
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition, diagnosis, and treatment of acute kidney rejection--the first 30 days.
    Howard RJ
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):92-103. PubMed ID: 2421468
    [No Abstract]   [Full Text] [Related]  

  • 19. Is chronic nephrotoxicity of cyclosporine avoided by the triple drug regimen?
    Hiesse C; Gardin JP; Lantz O; Cantarovich M; Bensadoun H; Benoit G; Bellamy J; Paillard M; Charpentier B; Fries D
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1534-6. PubMed ID: 2652495
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute renal failure after heart transplantation and cyclosporine therapy.
    McGiffin DC; Kirklin JK; Naftel DC
    J Heart Transplant; 1985; 4(4):396-9. PubMed ID: 3916513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.